Clinical Trials

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Number: NCT01492972
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Proton Collaborative Group
Sponsor Trial Information
Trial Location(s) and Contact(s)
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer

Number: NCT01581749
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): Albert DeNittis|Main Line Health
Sponsor Trial Information
Trial Location(s) and Contact(s)
Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy

Number: NCT03580499
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Jefferson University
Sponsor Trial Information
Trial Location(s) and Contact(s)
18F-DCFPyL PET-CT Scan and Prostate Cancer

Number: NCT03852654
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2| Phase 3
Sponsor(s): Lida Jafari|University of California, Los Angeles|VA Greater Los Angeles Healthcare System
Sponsor Trial Information
Trial Location(s) and Contact(s)
INTREPId (INTermediate Risk Erection PreservatIon Trial)

Number: NCT04025372
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dana-Farber Cancer Institute|Bayer|GenomeDx Biosciences Corp
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

Number: NCT04194554
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): University of Michigan Rogel Cancer Center|Janssen Scientific Affairs, LLC
Sponsor Trial Information
Trial Location(s) and Contact(s)
Trial of NanoPac Focal Therapy for Prostate Cancer

Number: NCT04221828
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): NanOlogy, LLC|US Biotest, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer

Number: NCT04457245
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Jonsson Comprehensive Cancer Center|Progenics Pharmaceuticals, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)

Total: 8 Clinical Trials

PHEN,Inc. © 2021 All rights reserved